22nd Century Group (XXII) Comments on the Advancement of New Zealand’s National Reduced Nicotine Content Law
December 13, 2022
New Study Again Shows 22nd Century’s Reduced Nicotine Content Cigarettes Reduce Cigarette Consumption and Increase Smoking Cessation
November 7, 2022
Cannabis Health Benefits Are Acknowledged By The New FDA Commissioner Nominee
Uncategorized November 14, 2021
Joe Biden’s Pick For New FDA Commissioner Uses Cannabis As Medicine
The post Cannabis Health Benefits Are Acknowledged By The New FDA Commissioner Nominee appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.
Read more
A CBD Trademark Suit Causes More Delays For The FDA To Develop Rules And Regulations
CBDMarijuana Industry NewsUncategorized September 10, 2021
The FDA Is Slow To Establish Rules And Regulations After New Trademark Ruling
The post A CBD Trademark Suit Causes More Delays For The FDA To Develop Rules And Regulations appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.
Read moreTryp Therapeutics Announces Phase 2a Clinical Trial for Fibromyalgia with the University of Michigan
July 21, 2021
Algernon Pharmaceuticals to File End-of-Phase 2 Meeting Request with U.S. FDA for Possible Ifenprodil Phase 3 COVID-19 Trial
April 8, 2021
Cardiol Therarpeutics Receives FDA Approval For Investigational New Drug (IND) Application For Phase II/III COVID-19 Trial
CBD September 25, 2020
While the U.S. Food and Drug Administration (“FDA”) continues to drag its feet in forging a clear path for the sale and marketing of hemp-derived cannabidiol (“Hemp CBD”) products, foreign agencies and industry players are leading the way by adopting their own sets of regulations. Last week, giant beauty retailer Sephora announced it was now…
Read more
